Remilk, which develops and produces animal-free dairy protein, has received a first-of-its-kind approval from the Israeli Ministry of Health (MOH). This clears a path for the marketing and sale of non-animal dairy products made with Remilk for Israeli consumers. It also establishes the country as one of the first in the world to offer people access to sustainable, real dairy made without cows and free of lactose, cholesterol, antibiotics and growth hormones.

The Ministry of Health approval follows Remilk's receipt of an FDA "No Questions Letter," confirming FDA acceptance of an expert panel's conclusion that Remilk's animal-free protein can be safely used in food products under its GRAS (Generally Recognized as Safe) standards, as well as a recent regulatory clearance from the Singapore Food Authority.

Remilk has raised more than $130 million to date and signed deals with several players in the global food industry. Last year, Remilk, which is already producing its protein at industrial volumes in facilities around the world, announced a large-scale commercial agreement with the Central Bottling Company (CBC Group), the exclusive Israeli franchisee of Coca-Cola, and one of the largest food companies in Israel, to launch a line of dairy products made with Remilk's protein, for the Israeli market.

"This is a defining moment, not only for Remilk, but for the entire global alternative protein industry and the state of Israel, one of the first in the world to recognize the significance of precision fermentation," said Aviv Wolff, CEO and co-founder of Remilk. "The opening of the Israeli market to real, animal-free dairy products will place Israel not only at the forefront of global food-tech research and development, but also as a leading market in the world for new food consumption. Today's news opens the door for the introduction of high-quality and nutritious animal-free dairy products."

"We thank the Ministry of Health for an in-depth process, in which our non-animal milk protein was thoroughly tested and found to be safe, of high-quality, and identical to its cow-derived counterpart," said Dr. Ori Cohavi, Chief Technology Officer (CTO) and co-founder of Remilk. "The breakthrough achievement of Remilk's R&D team lies in its success in converting a technology that has been used for decades to create components for the food industry such as vitamins and enzymes in small quantities, to produce one of the most significant and high-quality components in the food industry. Our milk protein, produced on an industrial scale, allows us to practically change the face of the dairy market."